Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fisetin Attenuates Diabetic Nephropathy-Induced Podocyte Injury by Inhibiting NLRP3 Inflammasome
Wenmin Dong, Chenglin Jia, Ji Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Flavonoids improve type 2 diabetes mellitus and its complications: a review
Xinrui Yi, Mosi Dong, Naifei Guo, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 48
Protective effect of orientin on diabetic nephropathy in rat models of high-fat diet and streptozotocin-induced diabetes
Raad Saad Luty, Adeeb Ahmed Al-Zubaidy, Arif Sami Malik, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access | Times Cited: 2
Paeoniflorin suppresses kidney inflammation by regulating macrophage polarization via KLF4-mediated mitophagy
Yiwen Cao, Jingli Xiong, Xueping Guan, et al.
Phytomedicine (2023) Vol. 116, pp. 154901-154901
Closed Access | Times Cited: 38
Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway
Chenlei Lv, Tianyang Cheng, Bingbing Zhang, et al.
Renal Failure (2023) Vol. 45, Iss. 1
Open Access | Times Cited: 31
Autophagy, Pyroptosis and Ferroptosis are Rising Stars in the Pathogenesis of Diabetic Nephropathy
Xiudan Li, Lifeng Gao, Xuyang Li, et al.
Diabetes Metabolic Syndrome and Obesity (2024) Vol. Volume 17, pp. 1289-1299
Open Access | Times Cited: 12
A Deep Insight into Ferroptosis in Renal Disease: Facts and Perspectives
Zhongyu Han, Yuanke Luo, Haoran Chen, et al.
Kidney Diseases (2024) Vol. 10, Iss. 3, pp. 224-236
Open Access | Times Cited: 11
Cellular senescence and kidney aging
Nikolai Rex, Anette Melk, Roland Schmitt
Clinical Science (2023) Vol. 137, Iss. 24, pp. 1805-1821
Open Access | Times Cited: 21
Fisetin, a Natural Polyphenol, Ameliorates Endometriosis Modulating Mast Cells Derived NLRP-3 Inflammasome Pathway and Oxidative Stress
Alessia Arangia, Ylenia Marino, Roberta Fusco, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5076-5076
Open Access | Times Cited: 18
Identification of endoplasmic reticulum stress-related biomarkers of diabetes nephropathy based on bioinformatics and machine learning
Jiaming Su, Jing Peng, Linlin Wang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 17
Micheliolide ameliorates lipopolysaccharide-induced acute kidney injury through suppression of NLRP3 activation by promoting mitophagy via Nrf2/PINK1/Parkin axis
Xianghong Lei, Jiyang Wang, Fengxia Zhang, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112527-112527
Closed Access | Times Cited: 7
Natural products in attenuating renal inflammation via inhibiting the NLRP3 inflammasome in diabetic kidney disease
Yan Wang, Zhun Sui, Mi Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Fisetin-loaded chitosan nanoparticles ameliorate pilocarpine-induced temporal lobe epilepsy and associated neurobehavioral alterations in mice: Role of ROS/TNF-α-NLRP3 inflammasomes pathway
Sagar Mahawar, Debarati Rakshit, Inklisan Patel, et al.
Nanomedicine Nanotechnology Biology and Medicine (2024) Vol. 59, pp. 102752-102752
Closed Access | Times Cited: 5
Podocyte OTUD5 alleviates diabetic kidney disease through deubiquitinating TAK1 and reducing podocyte inflammation and injury
Ying‐Yong Zhao, Shijie Fan, Hong Zhu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Breviscapine alleviates podocyte injury by inhibiting NF-κB/NLRP3-mediated pyroptosis in diabetic nephropathy
Linlin Sun, Miao Ding, Fuhua Chen, et al.
PeerJ (2023) Vol. 11, pp. e14826-e14826
Open Access | Times Cited: 12
Effects of Fisetin and Nicorandil on adjuvant-induced rheumatoid arthritis in rats: Emerging role of TLR4/NF-κB-induced Pyroptosis, Nrf-2/HO-1, and OPG/RANKL pathways
Asmaa H. Okasha, Islam Ibrahim Hegab, Monira A. Seleem, et al.
Cytokine (2025) Vol. 187, pp. 156876-156876
Closed Access
USP22 promotes angiotensin II-induced podocyte injury by deubiquitinating and stabilizing HMGB1
Zhuan Peng, Xiao‐Xiao Huang, Yangbin Pan, et al.
Cellular Signalling (2025) Vol. 131, pp. 111771-111771
Closed Access
Machine learning based identification of anoikis related gene classification patterns and immunoinfiltration characteristics in diabetic nephropathy
Jing Zhang, Lulu Cheng, Shan Jiang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Fisetin reduces the senescent tubular epithelial cell burden and also inhibits proliferative fibroblasts in murine lupus nephritis
Shogo Ijima, Yuki Saito, Kentaro Nagaoka, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 18
Regulation of autophagy by natural polyphenols in the treatment of diabetic kidney disease: therapeutic potential and mechanism
Tong‐Tong Liu, Qi Jin, Liping Yang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 10
NLRP3 concentration, oxidants, and antioxidants in plasma of endometriosis patients undergoing treatment with dienogest
Marziyeh Ajdary, Abolfazl Mehdizadeh Kashi, Roya Derakhshan, et al.
Journal of Gynecology Obstetrics and Human Reproduction (2024) Vol. 53, Iss. 3, pp. 102744-102744
Closed Access | Times Cited: 3
Targeting senescence to prevent diabetic kidney disease: Exploring molecular mechanisms and potential therapeutic targets for disease management
Paige Charlotte Alison Phillips, Mafalda de Sousa Loreto Aresta Branco, Chelsy L. Cliff, et al.
Diabetic Medicine (2024)
Open Access | Times Cited: 3
Molecular Mechanistic Pathways Targeted by Natural Compounds in the Prevention and Treatment of Diabetic Kidney Disease
Kaixuan Zhou, Zi Xue, Jiayu Song, et al.
Molecules (2022) Vol. 27, Iss. 19, pp. 6221-6221
Open Access | Times Cited: 15
The protective effects of fisetin in metabolic disorders: a focus on oxidative stress and associated events
Mahboobe Sattari, Jamal Amri, Mohammad Esmaeil Shahaboddin, et al.
Journal of Diabetes & Metabolic Disorders (2024) Vol. 23, Iss. 2, pp. 1753-1771
Closed Access | Times Cited: 2
Role of Innate Immune and Inflammatory Responses in the Development of Secondary Diabetic Complications
Trevor J. Plowman, Mujtaba H. Shah, Emely Fernandez, et al.
Current Molecular Medicine (2022) Vol. 23, Iss. 9, pp. 901-920
Closed Access | Times Cited: 11
Therapeutic targeting of mechanical stretch-induced FAK/ERK signaling by fisetin in hypertrophic scars
Haowei Lu, Hui Wang, Guohua Huang, et al.
European Journal of Pharmacology (2022) Vol. 932, pp. 175228-175228
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top